Global and Japan Circulating Tumor Cell Diagnostics Market 2020 by Company, Type and Application, Forecast to 2025

Publication Month: Mar 2020 | No. of Pages: 125 Published By: Global Info Research
Single User License: US $ 3980
Corporate User License: US $ 7960

Market Overview
The global Circulating Tumor Cell Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.8% in the forecast period of 2020 to 2025 and will expected to reach USD 6589.6 million by 2025, from USD 4701.9 million in 2019.

The Circulating Tumor Cell Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Circulating Tumor Cell Diagnostics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.

Breakdown by Type, Circulating Tumor Cell Diagnostics market has been segmented into CTC Enrichment, CTC Detection, CTC Analysis, etc.

Breakdown by Application, Circulating Tumor Cell Diagnostics has been segmented into Tumorigenesis research, EMT biomarkers development, Cancer stem cell research, Others, etc.

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Circulating Tumor Cell Diagnostics market presented in the report. This section sheds light on the sales growth of different regional and country-level Circulating Tumor Cell Diagnostics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Circulating Tumor Cell Diagnostics market.

For Japan, this report analyses the Japan market by players, Type and Application, for the period 2015-2025.

Competitive Landscape and Circulating Tumor Cell Diagnostics Market Share Analysis
Circulating Tumor Cell Diagnostics competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Circulating Tumor Cell Diagnostics revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2015-2020, this study provides the Circulating Tumor Cell Diagnostics revenue and market share for each player covered in this report.

The major players covered in Circulating Tumor Cell Diagnostics are: Janssen Diagnostics, Epic Sciences Inc., Biocept Inc, Advanced Cell Diagnostics, Clearbridge BioMedics Pte Ltd, Aviva Biosciences, ScreenCell, CellTraffix Inc., Biofluidica Inc., Fluxion Biosciences Inc., Apocell Inc, Creatv Microtech Inc, Silicon Biosystems, IV Diagnostics Inc, Biocep Ltd, AdnaGen AG, Sysmex Corporation, Ikonisys Inc, Canopus Bioscience Ltd, Greiner Bio-One GmbH, Miltenyi Biotech GmbH, Vitatex Inc, Nanostring Technologies Inc, Rarecells Diagnostics., etc. Among other players domestic and global, Circulating Tumor Cell Diagnostics market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Market segment by players, this report covers
Janssen Diagnostics
Epic Sciences Inc.
Biocept Inc
Advanced Cell Diagnostics
Clearbridge BioMedics Pte Ltd
Aviva Biosciences
ScreenCell
CellTraffix Inc.
Biofluidica Inc.
Fluxion Biosciences Inc.
Apocell Inc
Creatv Microtech Inc
Silicon Biosystems
IV Diagnostics Inc
Biocep Ltd
AdnaGen AG
Sysmex Corporation
Ikonisys Inc
Canopus Bioscience Ltd
Greiner Bio-One GmbH
Miltenyi Biotech GmbH
Vitatex Inc
Nanostring Technologies Inc
Rarecells Diagnostics.

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
MENA (Saudi Arabia, UAE, Turkey and South Africa)

Market segment by Type, covers:
CTC Enrichment
CTC Detection
CTC Analysis

Market segment by Application, can be divided into
Tumorigenesis research
EMT biomarkers development
Cancer stem cell research
Others

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Circulating Tumor Cell Diagnostics
1.2 Classification of Circulating Tumor Cell Diagnostics by Type
1.2.1 Overview: Global Circulating Tumor Cell Diagnostics Revenue by Type: 2015 Versus 2019 Versus 2025
1.2.2 Global Circulating Tumor Cell Diagnostics Revenue Market Share by Type in 2019
1.2.3 CTC Enrichment
1.2.4 CTC Detection
1.2.5 CTC Analysis
1.3 Global Circulating Tumor Cell Diagnostics Market by Application
1.3.1 Overview: Global Circulating Tumor Cell Diagnostics Revenue by Application: 2015 Versus 2019 Versus 2025
1.3.2 Tumorigenesis research
1.3.3 EMT biomarkers development
1.3.4 Cancer stem cell research
1.3.5 Others
1.4 Global Circulating Tumor Cell Diagnostics Market Size and Forecast (2015-2025)
1.5 Global Circulating Tumor Cell Diagnostics Market Size by Regions: 2015 VS 2019 VS 2025
1.6 Global Circulating Tumor Cell Diagnostics Market Size by Regions (2015-2020)
1.7 Global Circulating Tumor Cell Diagnostics Market Size and Forecast by Regions (2020-2025)
1.7.1 North America Circulating Tumor Cell Diagnostics Status and Prospect (2015-2025)
1.7.2 Europe Circulating Tumor Cell Diagnostics Status and Prospect (2015-2025)
1.7.3 Asia Circulating Tumor Cell Diagnostics Status and Prospect (2015-2025)
1.7.4 South America Circulating Tumor Cell Diagnostics Status and Prospect (2015-2025)
1.7.5 Middle East & Africa Circulating Tumor Cell Diagnostics Status and Prospect (2015-2025)

2 Company Profiles
2.1 Janssen Diagnostics
2.1.1 Janssen Diagnostics Details
2.1.2 Janssen Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Janssen Diagnostics SWOT Analysis
2.1.4 Janssen Diagnostics Product and Services
2.1.5 Janssen Diagnostics Circulating Tumor Cell Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Epic Sciences Inc.
2.2.1 Epic Sciences Inc. Details
2.2.2 Epic Sciences Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Epic Sciences Inc. SWOT Analysis
2.2.4 Epic Sciences Inc. Product and Services
2.2.5 Epic Sciences Inc. Circulating Tumor Cell Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Biocept Inc
2.3.1 Biocept Inc Details
2.3.2 Biocept Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Biocept Inc SWOT Analysis
2.3.4 Biocept Inc Product and Services
2.3.5 Biocept Inc Circulating Tumor Cell Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Advanced Cell Diagnostics
2.4.1 Advanced Cell Diagnostics Details
2.4.2 Advanced Cell Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Advanced Cell Diagnostics SWOT Analysis
2.4.4 Advanced Cell Diagnostics Product and Services
2.4.5 Advanced Cell Diagnostics Circulating Tumor Cell Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Clearbridge BioMedics Pte Ltd
2.5.1 Clearbridge BioMedics Pte Ltd Details
2.5.2 Clearbridge BioMedics Pte Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Clearbridge BioMedics Pte Ltd SWOT Analysis
2.5.4 Clearbridge BioMedics Pte Ltd Product and Services
2.5.5 Clearbridge BioMedics Pte Ltd Circulating Tumor Cell Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Aviva Biosciences
2.6.1 Aviva Biosciences Details
2.6.2 Aviva Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Aviva Biosciences SWOT Analysis
2.6.4 Aviva Biosciences Product and Services
2.6.5 Aviva Biosciences Circulating Tumor Cell Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.7 ScreenCell
2.7.1 ScreenCell Details
2.7.2 ScreenCell Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 ScreenCell SWOT Analysis
2.7.4 ScreenCell Product and Services
2.7.5 ScreenCell Circulating Tumor Cell Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.8 CellTraffix Inc.
2.8.1 CellTraffix Inc. Details
2.8.2 CellTraffix Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 CellTraffix Inc. SWOT Analysis
2.8.4 CellTraffix Inc. Product and Services
2.8.5 CellTraffix Inc. Circulating Tumor Cell Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Biofluidica Inc.
2.9.1 Biofluidica Inc. Details
2.9.2 Biofluidica Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Biofluidica Inc. SWOT Analysis
2.9.4 Biofluidica Inc. Product and Services
2.9.5 Biofluidica Inc. Circulating Tumor Cell Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Fluxion Biosciences Inc.
2.10.1 Fluxion Biosciences Inc. Details
2.10.2 Fluxion Biosciences Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Fluxion Biosciences Inc. SWOT Analysis
2.10.4 Fluxion Biosciences Inc. Product and Services
2.10.5 Fluxion Biosciences Inc. Circulating Tumor Cell Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.11 Apocell Inc
2.11.1 Apocell Inc Details
2.11.2 Apocell Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Apocell Inc SWOT Analysis
2.11.4 Apocell Inc Product and Services
2.11.5 Apocell Inc Circulating Tumor Cell Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.12 Creatv Microtech Inc
2.12.1 Creatv Microtech Inc Details
2.12.2 Creatv Microtech Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Creatv Microtech Inc SWOT Analysis
2.12.4 Creatv Microtech Inc Product and Services
2.12.5 Creatv Microtech Inc Circulating Tumor Cell Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.13 Silicon Biosystems
2.13.1 Silicon Biosystems Details
2.13.2 Silicon Biosystems Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Silicon Biosystems SWOT Analysis
2.13.4 Silicon Biosystems Product and Services
2.13.5 Silicon Biosystems Circulating Tumor Cell Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.14 IV Diagnostics Inc
2.14.1 IV Diagnostics Inc Details
2.14.2 IV Diagnostics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 IV Diagnostics Inc SWOT Analysis
2.14.4 IV Diagnostics Inc Product and Services
2.14.5 IV Diagnostics Inc Circulating Tumor Cell Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.15 Biocep Ltd
2.15.1 Biocep Ltd Details
2.15.2 Biocep Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Biocep Ltd SWOT Analysis
2.15.4 Biocep Ltd Product and Services
2.15.5 Biocep Ltd Circulating Tumor Cell Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.16 AdnaGen AG
2.16.1 AdnaGen AG Details
2.16.2 AdnaGen AG Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 AdnaGen AG SWOT Analysis
2.16.4 AdnaGen AG Product and Services
2.16.5 AdnaGen AG Circulating Tumor Cell Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.17 Sysmex Corporation
2.17.1 Sysmex Corporation Details
2.17.2 Sysmex Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Sysmex Corporation SWOT Analysis
2.17.4 Sysmex Corporation Product and Services
2.17.5 Sysmex Corporation Circulating Tumor Cell Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.18 Ikonisys Inc
2.18.1 Ikonisys Inc Details
2.18.2 Ikonisys Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Ikonisys Inc SWOT Analysis
2.18.4 Ikonisys Inc Product and Services
2.18.3 Ikonisys Inc Circulating Tumor Cell Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.19 Canopus Bioscience Ltd
2.19.1 Canopus Bioscience Ltd Details
2.19.2 Canopus Bioscience Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Canopus Bioscience Ltd SWOT Analysis
2.19.4 Canopus Bioscience Ltd Product and Services
2.19.5 Canopus Bioscience Ltd Circulating Tumor Cell Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.20 Greiner Bio-One GmbH
2.20.1 Greiner Bio-One GmbH Details
2.20.2 Greiner Bio-One GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Greiner Bio-One GmbH SWOT Analysis
2.20.4 Greiner Bio-One GmbH Product and Services
2.20.5 Greiner Bio-One GmbH Circulating Tumor Cell Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.21 Miltenyi Biotech GmbH
2.21.1 Miltenyi Biotech GmbH Details
2.21.2 Miltenyi Biotech GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 Miltenyi Biotech GmbH SWOT Analysis
2.21.4 Miltenyi Biotech GmbH Product and Services
2.21.5 Miltenyi Biotech GmbH Circulating Tumor Cell Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.22 Vitatex Inc
2.22.1 Vitatex Inc Details
2.22.2 Vitatex Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.22.3 Vitatex Inc SWOT Analysis
2.22.4 Vitatex Inc Product and Services
2.22.5 Vitatex Inc Circulating Tumor Cell Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.23 Nanostring Technologies Inc
2.23.1 Nanostring Technologies Inc Details
2.23.2 Nanostring Technologies Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.23.3 Nanostring Technologies Inc SWOT Analysis
2.23.4 Nanostring Technologies Inc Product and Services
2.23.5 Nanostring Technologies Inc Circulating Tumor Cell Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.24 Rarecells Diagnostics.
2.24.1 Rarecells Diagnostics. Details
2.24.2 Rarecells Diagnostics. Major Business and Total Revenue (Financial Highlights) Analysis
2.24.3 Rarecells Diagnostics. SWOT Analysis
2.24.4 Rarecells Diagnostics. Product and Services
2.24.5 Rarecells Diagnostics. Circulating Tumor Cell Diagnostics Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players
3.1 Global Circulating Tumor Cell Diagnostics Market Size by Players (2015-2020)
3.2 Japan Circulating Tumor Cell Diagnostics Market Size by Players (2015-2020)
3.3 Market Concentration Rate
3.3.1 Top 5 Circulating Tumor Cell Diagnostics Players Market Share
3.3.2 Top 10 Circulating Tumor Cell Diagnostics Players Market Share

4 North America Market Size and Forecast by Countries
4.1 North America Circulating Tumor Cell Diagnostics Market Size by Countries (2015-2020)
4.2 North America Circulating Tumor Cell Diagnostics Market Size and Forecast by Countries (2015-2026)
4.3 United States Circulating Tumor Cell Diagnostics Market Size and Forecast (2015-2025)
4.4 Canada Circulating Tumor Cell Diagnostics Market Size and Forecast (2015-2025)
4.5 Mexico Circulating Tumor Cell Diagnostics Market Size and Forecast (2015-2025)

5 Europe Market Size and Forecast by Countries
5.1 Europe Circulating Tumor Cell Diagnostics Market Size by Countries (2015-2020)
5.2 Europe Circulating Tumor Cell Diagnostics Market Size and Forecast by Countries (2015-2026)
5.3 Germany Circulating Tumor Cell Diagnostics Market Size and Forecast (2015-2025)
5.4 France Circulating Tumor Cell Diagnostics Market Size and Forecast (2015-2025)
5.5 UK Circulating Tumor Cell Diagnostics Market Size and Forecast (2015-2025)
5.6 Russia Circulating Tumor Cell Diagnostics Market Size and Forecast (2015-2025)
5.7 Italy Circulating Tumor Cell Diagnostics Market Size and Forecast (2015-2025)

6 Asia-Pacific Market Size and Forecast by Countries
6.1 Asia-Pacific Circulating Tumor Cell Diagnostics Market Size by Regions (2015-2020)
6.2 Asia-Pacific Circulating Tumor Cell Diagnostics Market Size and Forecast by Regions (2015-2026)
6.3 China Circulating Tumor Cell Diagnostics Market Size and Forecast (2015-2025)
6.4 Japan Circulating Tumor Cell Diagnostics Market Size and Forecast (2015-2025)
6.5 Korea Circulating Tumor Cell Diagnostics Market Size and Forecast (2015-2025)
6.6 India Circulating Tumor Cell Diagnostics Market Size and Forecast (2015-2025)
6.7 Southeast Asia Circulating Tumor Cell Diagnostics Market Size and Forecast (2015-2025)

7 South America Market Size and Forecast by Countries
7.1 South America Circulating Tumor Cell Diagnostics Market Size by Countries (2015-2020)
7.2 South America Circulating Tumor Cell Diagnostics Market Size and Forecast by Countries (2015-2026)
7.3 Brazil Circulating Tumor Cell Diagnostics Market Size and Forecast (2015-2025)
7.4 Argentina Circulating Tumor Cell Diagnostics Market Size and Forecast (2015-2025)

8 Middle East & Africa Market Size and Forecast by Countries
8.1 Middle East & Africa Circulating Tumor Cell Diagnostics Revenue by Regions (2015-2020)
8.2 Middle East & Africa Circulating Tumor Cell Diagnostics Market Size and Forecast by Countries (2015-2026)
8.3 Saudi Arabia Circulating Tumor Cell Diagnostics Market Size and Forecast (2015-2025)
8.4 UAE Circulating Tumor Cell Diagnostics Market Size and Forecast (2015-2025)
8.5 Egypt Circulating Tumor Cell Diagnostics Market Size and Forecast (2015-2025)
8.6 South Africa Circulating Tumor Cell Diagnostics Market Size and Forecast (2015-2025)

9 Market Size Segment by Type
9.1 Global Circulating Tumor Cell Diagnostics Market Size and Forecast by Type (2015-2025)
9.1.1 Global Circulating Tumor Cell Diagnostics Market Size by Type (2015-2020)
9.1.2 Global Circulating Tumor Cell Diagnostics Market Size Forecast by Type (2020-2025)
9.2 Japan Circulating Tumor Cell Diagnostics Market Size and Forecast by Type (2015-2025)
9.2.1 Japan Circulating Tumor Cell Diagnostics Market Size by Type (2015-2020)
9.2.2 Japan Circulating Tumor Cell Diagnostics Market Size Forecast by Type (2020-2025)

10 Market Size Segment by Application
10.1 Global Circulating Tumor Cell Diagnostics Market Size and Forecast by Application (2015-2025)
10.1.1 Global Circulating Tumor Cell Diagnostics Market Size by Application (2015-2020)
10.1.2 Global Circulating Tumor Cell Diagnostics Market Size Forecast by Application (2020-2025)
10.2 Japan Circulating Tumor Cell Diagnostics Market Size and Forecast by Application (2015-2025)
10.2.1 Japan Circulating Tumor Cell Diagnostics Market Size by Application (2015-2020)
10.2.2 Japan Circulating Tumor Cell Diagnostics Market Size Forecast by Application (2020-2025)

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Data Source
12.3 Disclaimer
12.4 About US

Tables and Figures

List of Tables

Table 1. Global Circulating Tumor Cell Diagnostics Revenue (USD Million) by Type: 2015 Versus 2019 Versus 2025
Table 2. Breakdown of Circulating Tumor Cell Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Circulating Tumor Cell Diagnostics Revenue (USD Million) by Application: 2015 Versus 2019 Versus 2025
Table 4. Global Market Circulating Tumor Cell Diagnostics Market Size (USD Million) Comparison by Regions (2020-2025)
Table 5. Global Circulating Tumor Cell Diagnostics Revenue (USD Million) by Regions (2015-2020)
Table 6. Global Circulating Tumor Cell Diagnostics Revenue Share by Regions (2015-2020)
Table 7. Global Circulating Tumor Cell Diagnostics Revenue (USD Million) by Regions (2020-2025)
Table 8. Global Circulating Tumor Cell Diagnostics Revenue Market Share by Regions (2020-2025)
Table 9. Janssen Diagnostics Corporate Information, Location and Competitors
Table 10. Janssen Diagnostics Major Business
Table 11. Janssen Diagnostics Circulating Tumor Cell Diagnostics Total Revenue (USD Million) (2017-2018)
Table 12. Janssen Diagnostics SWOT Analysis
Table 13. Janssen Diagnostics Circulating Tumor Cell Diagnostics Product and Solutions
Table 14. Janssen Diagnostics Circulating Tumor Cell Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 15. Epic Sciences Inc. Corporate Information, Location and Competitors
Table 16. Epic Sciences Inc. Major Business
Table 17. Epic Sciences Inc. Circulating Tumor Cell Diagnostics Total Revenue (USD Million) (2018-2019)
Table 18. Epic Sciences Inc. SWOT Analysis
Table 19. Epic Sciences Inc. Circulating Tumor Cell Diagnostics Product and Solutions
Table 20. Epic Sciences Inc. Circulating Tumor Cell Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 21. Biocept Inc Corporate Information, Location and Competitors
Table 22. Biocept Inc Major Business
Table 23. Biocept Inc Circulating Tumor Cell Diagnostics Total Revenue (USD Million) (2017-2018)
Table 24. Biocept Inc SWOT Analysis
Table 25. Biocept Inc Circulating Tumor Cell Diagnostics Product and Solutions
Table 26. Biocept Inc Circulating Tumor Cell Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 27. Advanced Cell Diagnostics Corporate Information, Location and Competitors
Table 28. Advanced Cell Diagnostics Major Business
Table 29. Advanced Cell Diagnostics Circulating Tumor Cell Diagnostics Total Revenue (USD Million) (2017-2018)
Table 30. Advanced Cell Diagnostics SWOT Analysis
Table 31. Advanced Cell Diagnostics Circulating Tumor Cell Diagnostics Product and Solutions
Table 32. Advanced Cell Diagnostics Circulating Tumor Cell Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 33. Clearbridge BioMedics Pte Ltd Corporate Information, Location and Competitors
Table 34. Clearbridge BioMedics Pte Ltd Major Business
Table 35. Clearbridge BioMedics Pte Ltd Circulating Tumor Cell Diagnostics Total Revenue (USD Million) (2017-2018)
Table 36. Clearbridge BioMedics Pte Ltd SWOT Analysis
Table 37. Clearbridge BioMedics Pte Ltd Circulating Tumor Cell Diagnostics Product and Solutions
Table 38. Clearbridge BioMedics Pte Ltd Circulating Tumor Cell Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 39. Aviva Biosciences Corporate Information, Location and Competitors
Table 40. Aviva Biosciences Major Business
Table 41. Aviva Biosciences Circulating Tumor Cell Diagnostics Total Revenue (USD Million) (2017-2018)
Table 42. Aviva Biosciences SWOT Analysis
Table 43. Aviva Biosciences Circulating Tumor Cell Diagnostics Product and Solutions
Table 44. Aviva Biosciences Circulating Tumor Cell Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 45. ScreenCell Corporate Information, Location and Competitors
Table 46. ScreenCell Major Business
Table 47. ScreenCell Circulating Tumor Cell Diagnostics Total Revenue (USD Million) (2017-2018)
Table 48. ScreenCell SWOT Analysis
Table 49. ScreenCell Circulating Tumor Cell Diagnostics Product and Solutions
Table 50. ScreenCell Circulating Tumor Cell Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 51. CellTraffix Inc. Corporate Information, Location and Competitors
Table 52. CellTraffix Inc. Major Business
Table 53. CellTraffix Inc. Circulating Tumor Cell Diagnostics Total Revenue (USD Million) (2017-2018)
Table 54. CellTraffix Inc. SWOT Analysis
Table 55. CellTraffix Inc. Circulating Tumor Cell Diagnostics Product and Solutions
Table 56. CellTraffix Inc. Circulating Tumor Cell Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 57. Biofluidica Inc. Corporate Information, Location and Competitors
Table 58. Biofluidica Inc. Major Business
Table 59. Biofluidica Inc. Circulating Tumor Cell Diagnostics Total Revenue (USD Million) (2017-2018)
Table 60. Biofluidica Inc. SWOT Analysis
Table 61. Biofluidica Inc. Circulating Tumor Cell Diagnostics Product and Solutions
Table 62. Biofluidica Inc. Circulating Tumor Cell Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 63. Fluxion Biosciences Inc. Corporate Information, Location and Competitors
Table 64. Fluxion Biosciences Inc. Major Business
Table 65. Fluxion Biosciences Inc. Circulating Tumor Cell Diagnostics Total Revenue (USD Million) (2017-2018)
Table 66. Fluxion Biosciences Inc. SWOT Analysis
Table 67. Fluxion Biosciences Inc. Circulating Tumor Cell Diagnostics Product and Solutions
Table 68. Fluxion Biosciences Inc. Circulating Tumor Cell Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 69. Apocell Inc Corporate Information, Location and Competitors
Table 70. Apocell Inc Major Business
Table 71. Apocell Inc Circulating Tumor Cell Diagnostics Total Revenue (USD Million) (2017-2018)
Table 72. Apocell Inc SWOT Analysis
Table 73. Apocell Inc Circulating Tumor Cell Diagnostics Product and Solutions
Table 74. Apocell Inc Circulating Tumor Cell Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 75. Creatv Microtech Inc Corporate Information, Location and Competitors
Table 76. Creatv Microtech Inc Major Business
Table 77. Creatv Microtech Inc Circulating Tumor Cell Diagnostics Total Revenue (USD Million) (2017-2018)
Table 78. Creatv Microtech Inc SWOT Analysis
Table 79. Creatv Microtech Inc Circulating Tumor Cell Diagnostics Product and Solutions
Table 80. Creatv Microtech Inc Circulating Tumor Cell Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 81. Silicon Biosystems Corporate Information, Location and Competitors
Table 82. Silicon Biosystems Major Business
Table 83. Silicon Biosystems Circulating Tumor Cell Diagnostics Total Revenue (USD Million) (2017-2018)
Table 84. Silicon Biosystems SWOT Analysis
Table 85. Silicon Biosystems Circulating Tumor Cell Diagnostics Product and Solutions
Table 86. Silicon Biosystems Circulating Tumor Cell Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 87. IV Diagnostics Inc Corporate Information, Location and Competitors
Table 88. IV Diagnostics Inc Major Business
Table 89. IV Diagnostics Inc Circulating Tumor Cell Diagnostics Total Revenue (USD Million) (2017-2018)
Table 90. IV Diagnostics Inc SWOT Analysis
Table 91. IV Diagnostics Inc Circulating Tumor Cell Diagnostics Product and Solutions
Table 92. IV Diagnostics Inc Circulating Tumor Cell Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 93. Biocep Ltd Corporate Information, Location and Competitors
Table 94. Biocep Ltd Major Business
Table 95. Biocep Ltd Circulating Tumor Cell Diagnostics Total Revenue (USD Million) (2017-2018)
Table 96. Biocep Ltd SWOT Analysis
Table 97. Biocep Ltd Circulating Tumor Cell Diagnostics Product and Solutions
Table 98. Biocep Ltd Circulating Tumor Cell Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 99. AdnaGen AG Corporate Information, Location and Competitors
Table 100. AdnaGen AG Major Business
Table 101. AdnaGen AG Circulating Tumor Cell Diagnostics Total Revenue (USD Million) (2017-2018)
Table 102. AdnaGen AG SWOT Analysis
Table 103. AdnaGen AG Circulating Tumor Cell Diagnostics Product and Solutions
Table 104. AdnaGen AG Circulating Tumor Cell Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 105. Sysmex Corporation Corporate Information, Location and Competitors
Table 106. Sysmex Corporation Major Business
Table 107. Sysmex Corporation Circulating Tumor Cell Diagnostics Total Revenue (USD Million) (2017-2018)
Table 108. Sysmex Corporation SWOT Analysis
Table 109. Sysmex Corporation Circulating Tumor Cell Diagnostics Product and Solutions
Table 110. Sysmex Corporation Circulating Tumor Cell Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 111. Ikonisys Inc Circulating Tumor Cell Diagnostics Type and Application
Table 112. Ikonisys Inc Major Business
Table 113. Ikonisys Inc Circulating Tumor Cell Diagnostics Total Revenue (USD Million) (2017-2018)
Table 114. Ikonisys Inc SWOT Analysis
Table 115. Ikonisys Inc Circulating Tumor Cell Diagnostics Product and Solutions
Table 116. Ikonisys Inc Circulating Tumor Cell Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 117. Canopus Bioscience Ltd Corporate Information, Location and Competitors
Table 118. Canopus Bioscience Ltd Major Business
Table 119. Canopus Bioscience Ltd Circulating Tumor Cell Diagnostics Total Revenue (USD Million) (2017-2018)
Table 120. Canopus Bioscience Ltd SWOT Analysis
Table 121. Canopus Bioscience Ltd Circulating Tumor Cell Diagnostics Product and Solutions
Table 122. Canopus Bioscience Ltd Circulating Tumor Cell Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 123. Greiner Bio-One GmbH Corporate Information, Location and Competitors
Table 124. Greiner Bio-One GmbH Major Business
Table 125. Greiner Bio-One GmbH Circulating Tumor Cell Diagnostics Total Revenue (USD Million) (2017-2018)
Table 126. Greiner Bio-One GmbH SWOT Analysis
Table 127. Greiner Bio-One GmbH Circulating Tumor Cell Diagnostics Product and Solutions
Table 128. Greiner Bio-One GmbH Circulating Tumor Cell Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 129. Miltenyi Biotech GmbH Corporate Information, Location and Competitors
Table 130. Miltenyi Biotech GmbH Major Business
Table 131. Miltenyi Biotech GmbH Circulating Tumor Cell Diagnostics Total Revenue (USD Million) (2017-2018)
Table 132. Miltenyi Biotech GmbH SWOT Analysis
Table 133. Miltenyi Biotech GmbH Circulating Tumor Cell Diagnostics Product and Solutions
Table 134. Miltenyi Biotech GmbH Circulating Tumor Cell Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 135. Vitatex Inc Corporate Information, Location and Competitors
Table 136. Vitatex Inc Major Business
Table 137. Vitatex Inc Circulating Tumor Cell Diagnostics Total Revenue (USD Million) (2017-2018)
Table 138. Vitatex Inc SWOT Analysis
Table 139. Vitatex Inc Circulating Tumor Cell Diagnostics Product and Solutions
Table 140. Vitatex Inc Circulating Tumor Cell Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 141. Nanostring Technologies Inc Corporate Information, Location and Competitors
Table 142. Nanostring Technologies Inc Major Business
Table 143. Nanostring Technologies Inc Circulating Tumor Cell Diagnostics Total Revenue (USD Million) (2017-2018)
Table 144. Nanostring Technologies Inc SWOT Analysis
Table 145. Nanostring Technologies Inc Circulating Tumor Cell Diagnostics Product and Solutions
Table 146. Nanostring Technologies Inc Circulating Tumor Cell Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 147. Rarecells Diagnostics. Corporate Information, Location and Competitors
Table 148. Rarecells Diagnostics. Major Business
Table 149. Rarecells Diagnostics. Circulating Tumor Cell Diagnostics Total Revenue (USD Million) (2017-2018)
Table 150. Rarecells Diagnostics. SWOT Analysis
Table 151. Rarecells Diagnostics. Circulating Tumor Cell Diagnostics Product and Solutions
Table 152. Rarecells Diagnostics. Circulating Tumor Cell Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 153. Global Circulating Tumor Cell Diagnostics Revenue (USD Million) by Players (2015-2020)
Table 154. Global Circulating Tumor Cell Diagnostics Revenue Share by Players (2015-2020)
Table 155. Key Players Circulating Tumor Cell Diagnostics Revenue (USD Million) in Japan (2015-2020)
Table 156. Key Players Circulating Tumor Cell Diagnostics Revenue Share in Japan (2015-2020)
Table 157. North America Circulating Tumor Cell Diagnostics Revenue (USD Million) by Countries (2015-2020)
Table 158. North America Circulating Tumor Cell Diagnostics Revenue Market Share by Countries (2015-2020)
Table 159. North America Circulating Tumor Cell Diagnostics Revenue (USD Million) by Countries (2020-2026)
Table 160. North America Circulating Tumor Cell Diagnostics Revenue Market Share by Countries (2020-2026)
Table 161. Europe Circulating Tumor Cell Diagnostics Revenue (USD Million) by Countries (2015-2020)
Table 162. Europe Circulating Tumor Cell Diagnostics Revenue Market Share by Countries (2015-2020)
Table 163. Europe Circulating Tumor Cell Diagnostics Revenue (USD Million) by Countries (2020-2026)
Table 164. Europe Circulating Tumor Cell Diagnostics Revenue Market Share by Countries (2020-2026)
Table 165. Asia-Pacific Circulating Tumor Cell Diagnostics Revenue (USD Million) by Countries (2015-2020)
Table 166. Asia-Pacific Circulating Tumor Cell Diagnostics Revenue Market Share by Countries (2015-2020)
Table 167. Asia-Pacific Circulating Tumor Cell Diagnostics Revenue (USD Million) by Countries (2020-2026)
Table 168. Asia-Pacific Circulating Tumor Cell Diagnostics Revenue Market Share by Countries (2020-2026)
Table 169. South America Circulating Tumor Cell Diagnostics Revenue (USD Million) by Countries (2015-2020)
Table 170. South America Circulating Tumor Cell Diagnostics Revenue Market Share by Countries (2015-2020)
Table 171. South America Circulating Tumor Cell Diagnostics Revenue (USD Million) by Countries (2020-2026)
Table 172. South America Circulating Tumor Cell Diagnostics Revenue Market Share by Countries (2020-2026)
Table 173. Middle East & Africa Circulating Tumor Cell Diagnostics Revenue (USD Million) by Countries (2015-2020)
Table 174. Middle East & Africa Circulating Tumor Cell Diagnostics Revenue Market Share by Countries (2015-2020)
Table 175. Middle East & Africa Circulating Tumor Cell Diagnostics Revenue (USD Million) by Countries (2020-2026)
Table 176. Middle East & Africa Circulating Tumor Cell Diagnostics Revenue Market Share by Countries (2020-2026)
Table 177. Global Circulating Tumor Cell Diagnostics Revenue (USD Million) by Type (2015-2020)
Table 178. Global Circulating Tumor Cell Diagnostics Revenue Share by Type (2015-2020)
Table 179. Global Circulating Tumor Cell Diagnostics Revenue Forecast by Type (2020-2025)
Table 180. Global Circulating Tumor Cell Diagnostics Market Share Forecast by Type (2020-2025)
Table 181. Japan Circulating Tumor Cell Diagnostics Revenue (USD Million) by Type (2015-2020)
Table 182. Japan Circulating Tumor Cell Diagnostics Revenue Share by Type (2015-2020)
Table 183. Japan Circulating Tumor Cell Diagnostics Revenue Forecast by Type (2020-2025)
Table 184. Japan Circulating Tumor Cell Diagnostics Market Share Forecast by Type (2020-2025)
Table 185. Global Circulating Tumor Cell Diagnostics Revenue (USD Million) by Application (2015-2020)
Table 186. Global Circulating Tumor Cell Diagnostics Revenue Share by Application (2015-2020)
Table 187. Global Circulating Tumor Cell Diagnostics Revenue Forecast by Application (2020-2025)
Table 188. Global Circulating Tumor Cell Diagnostics Market Share Forecast by Application (2020-2025)
Table 189. Japan Circulating Tumor Cell Diagnostics Revenue (USD Million) by Application (2015-2020)
Table 190. Japan Circulating Tumor Cell Diagnostics Revenue Share by Application (2015-2020)
Table 191. Japan Circulating Tumor Cell Diagnostics Revenue Forecast by Application (2020-2025)
Table 192. Japan Circulating Tumor Cell Diagnostics Market Share Forecast by Application (2020-2025)
List of Figures
Figure 1. Circulating Tumor Cell Diagnostics Picture
Figure 2. Global Circulating Tumor Cell Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. Global Circulating Tumor Cell Diagnostics Revenue Market Share by Type in 2019
Figure 4. CTC Enrichment Picture
Figure 5. CTC Detection Picture
Figure 6. CTC Analysis Picture
Figure 7. Circulating Tumor Cell Diagnostics Revenue Market Share by Application in 2019
Figure 8. Tumorigenesis research Picture
Figure 9. EMT biomarkers development Picture
Figure 10. Cancer stem cell research Picture
Figure 11. Others Picture
Figure 12. Global Circulating Tumor Cell Diagnostics Revenue and Growth Rate (2015-2025) (USD Million)
Figure 13. Global Circulating Tumor Cell Diagnostics Market Size Share by Regions (2015-2025)
Figure 14. Global Circulating Tumor Cell Diagnostics Market Size Share by Regions in 2019
Figure 15. Global Circulating Tumor Cell Diagnostics Revenue Market Share by Regions (2020-2025)
Figure 16. North America Circulating Tumor Cell Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 17. Europe Circulating Tumor Cell Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 18. Asia-Pacific Circulating Tumor Cell Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 19. South America Circulating Tumor Cell Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 20. Middle East & Africa Circulating Tumor Cell Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 21. Global Circulating Tumor Cell Diagnostics Revenue Share by Players in 2019
Figure 22. Global Top 5 Players Circulating Tumor Cell Diagnostics Revenue Market Share in 2019
Figure 23. Top 10 Players Circulating Tumor Cell Diagnostics Revenue Market Share in Global Market in 2019
Figure 24. Global Circulating Tumor Cell Diagnostics Market Size (USD Million) by Type (2015-2025)
Figure 25. Global Circulating Tumor Cell Diagnostics Market Size Share by Application (2015-2025)
Figure 26. North America Circulating Tumor Cell Diagnostics Market Size Share by Countries (2015-2025)
Figure 27. North America Circulating Tumor Cell Diagnostics Market Size Share by Countries in 2019
Figure 28. United States Circulating Tumor Cell Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 29. Canada Circulating Tumor Cell Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 30. Mexico Circulating Tumor Cell Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 31. Europe Circulating Tumor Cell Diagnostics Market Size Share by Countries (2015-2025)
Figure 32. Europe Circulating Tumor Cell Diagnostics Market Size Share by Countries in 2019
Figure 33. Germany Circulating Tumor Cell Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 34. France Circulating Tumor Cell Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 35. Russia Circulating Tumor Cell Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 36. Italy Circulating Tumor Cell Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 37. Spain Circulating Tumor Cell Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 38. UK Circulating Tumor Cell Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 39. Asia Circulating Tumor Cell Diagnostics Market Size Share by Countries (2015-2025)
Figure 40. Asia Circulating Tumor Cell Diagnostics Market Size Share by Countries in 2019
Figure 41. China Circulating Tumor Cell Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 42. Japan Circulating Tumor Cell Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 43. Korea Circulating Tumor Cell Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 44. India Circulating Tumor Cell Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 45. Southeast Asia Circulating Tumor Cell Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 46. South America Circulating Tumor Cell Diagnostics Market Size Share by Countries (2015-2025)
Figure 47. South America Circulating Tumor Cell Diagnostics Market Size Share by Countries in 2019
Figure 48. Brazil Circulating Tumor Cell Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 49. Argentina Circulating Tumor Cell Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 50. Middle East & Africa Circulating Tumor Cell Diagnostics Market Size Share by Countries (2015-2025)
Figure 51. Middle East & Africa Circulating Tumor Cell Diagnostics Market Size Share by Countries in 2019
Figure 52. Saudi Arabia Circulating Tumor Cell Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 53. UAE Circulating Tumor Cell Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 54. Egypt Circulating Tumor Cell Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 55. South Africa Circulating Tumor Cell Diagnostics Market Size (USD Million) and Forecast (2015-2025)
Figure 56. Global Circulating Tumor Cell Diagnostics Revenue Share by Type (2015-2020)
Figure 57. Japan Circulating Tumor Cell Diagnostics Revenue Share by Type (2015-2020)
Figure 58. Global Circulating Tumor Cell Diagnostics Revenue Share by Application (2015-2020)
Figure 59. Japan Circulating Tumor Cell Diagnostics Revenue Share by Application (2015-2020)




Companies Mentioned
Janssen Diagnostics
Epic Sciences Inc.
Biocept Inc
Advanced Cell Diagnostics
Clearbridge BioMedics Pte Ltd
Aviva Biosciences
ScreenCell
CellTraffix Inc.
Biofluidica Inc.
Fluxion Biosciences Inc.
Apocell Inc
Creatv Microtech Inc
Silicon Biosystems
IV Diagnostics Inc
Biocep Ltd
AdnaGen AG
Sysmex Corporation
Ikonisys Inc
Canopus Bioscience Ltd
Greiner Bio-One GmbH
Miltenyi Biotech GmbH
Vitatex Inc
Nanostring Technologies Inc
Rarecells Diagnostics.

Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets